Clinical studies and our extensive patient experience at Internal Medicine and Family Practice show that the vast majority of patients experience a substantial decrease in hunger and achieve meaningful weight loss
Semaglutide offers several benefits that are helpful for patients with chronic kidney disease, including: Lowering blood sugar without increasing the risk of low blood sugar Supporting steady weight loss, which helps ease pressure on the kidneys Slowing digestion and reducing appetite, leading to improved blood sugar control Reducing inflammation, which is known to make chronic kidney disease worse Helping protect blood vessels, including those in the kidneys These effects combine to create a treatment that may slow down the loss of kidney function in people with diabetes and early-stage chronic kidney disease
According to the Summary of Product Characteristics (SmPC) approved by the Medicines and Healthcare products Regulatory Agency (MHRA), common adverse effects include: Nausea (very common, affecting more than 1 in 10 patients) Diarrhoea (very common) Vomiting (common, affecting up to 1 in 10 patients) Constipation (common) Abdominal pain (common) Dyspepsia (common) Decreased appetite (very common) Abdominal distension (common) Flatulence and eructation (common) Injection-site reactions (common) These gastrointestinal symptoms typically diminish over time as the body adjusts to the medication
Exercise: Regular Physical Activity: Combining cardiovascular and strength training exercises helps improve fitness levels and overall health
Ondansetron is a prescription medication that can prevent nausea and vomiting caused by various medical conditions, including chemotherapy and radiation
